Table 1 Patient characteristics of the study population
Total population, n (%) | 98 (100.0) |
|---|---|
Caucasian, n (%) | 98 (100.0) |
Male, n (%) | 73 (74.5) |
Smoking status | |
Smokers, n (%) | 38 (38.8) |
Ex-smokers, n (%) | 54 (55.1) |
Unknown, n (%) | 6 (6.1) |
Age, mean (SD), years | 71.1 (10.3) |
FEV1% predicted, mean (SD)a | 60.1 (18.2) |
Spirometric GOLD grade, n (%) | |
Grade 1 | 20 (20.4) |
Grade 2 | 51 (52.0) |
Grade 3 | 22 (22.4) |
Grade 4 | 5 (5.1) |
BMI, mean (SD), kg/m2 | 24.9 (5.7) |
Patients with at least one exacerbation, n (%) | 58 (59.2) |
Patients with at least one severe exacerbation, n (%) | 29 (29.6) |
Comorbidities, n (%) | 132 (100.0) |
Hypertension | 28 (21.2) |
Gastroesophageal reflux | 21 (15.9) |
Arrhythmia | 19 (14.4) |
Depression | 14 (10.6) |
Ischaemic heart disease | 12 (9.1) |
Metabolic syndrome and diabetes | 10 (7.6) |
Peripheral vascular disease | 10 (7.6) |
Anxiety | 4 (3.0) |
Osteoporosis | 4 (3.0) |
Obstructive sleep apnea | 3 (2.3) |
Bronchiectasis | 1 (0.8) |
Lung cancer | 0 (0.0) |